debate: induction therapy for multiple myeloma - based on an imid and a proteasome inhibitor
Published 7 years ago • 108 plays • Length 13:17Download video MP4
Download video MP3
Similar videos
-
12:54
debate: induction therapy for multiple myeloma - based on an imid and a monoclonal antibody
-
16:14
debate: what is the best induction therapy in transplant-eligible myeloma patients? - combination
-
19:19
personalized precision approaches in multiple myeloma: a focus on proteasome inhibitors
-
14:37
debate: standard induction for myeloma - rvd
-
13:37
debate: optimal induction therapy for newly diagnosed transplant eligible myeloma - triplets
-
17:26
debate: to maintain or not to maintain? immunomodulators vs. pi - yes (proteasome inhibitors)
-
29:45
debate: ideal treatment fro smoldering myeloma
-
13:27
patient & family seminar 2024 | advancements in myeloma treatment strategies: multiple drugs upfront
-
15:31
debate: to maintain or not to maintain in myeloma? - no, but if you must, use a proteasome inhibitor
-
13:36
debate: what is the best induction therapy in transplant-eligible myeloma patients? - sequential
-
13:10
debate: is transplant a necessity or a choice for myeloma patients? - yes
-
12:32
debate: myeloma maintenance post-transplant - indefinite
-
20:58
management of a fit patient: induction, which one to choose, 3 or 4 drugs
-
40:06
multiple myeloma: a pathway to better outcomes
-
12:00
debate: is allotransplant relevant today in myeloma? - no
-
13:34
debate: is allotransplant relevant today in myeloma? - yes
-
10:50
debate: use of mrd measurements in myeloma - not yet ready for prime time in standard care
-
9:19
debate: is transplant a necessity or a choice for myeloma patients? - no
-
16:22
debate: salvage therapy for multiple myeloma - should be the same for everyone